First Trust Indxx Medical Devices ETF
MDEV
3 hedge funds and large institutions have $935K invested in First Trust Indxx Medical Devices ETF in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0.5% more ownership
Funds ownership: 46.3% → 46.8% (+0.5%)
2% less capital invested
Capital invested by funds: $951K → $935K (-$16.1K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$50K |
| 2 |
VF
Virtu Financial
New York
|
+$2.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
-$42.8K |
MDEV Hedge Fund Activity: Q3 2025 in Review
3 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in First Trust Indxx Medical Devices ETF (MDEV) for Q3 2025, worth a combined $935K — down 1.7% from $951K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MDEV and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Jane Street, adding an estimated $50K. The largest seller was Arax Advisory Partners, exiting entirely with an estimated $42.8K sold.
- 3 institutional investors held First Trust Indxx Medical Devices ETF (MDEV) as of Q3 2025, down from 4 in Q2 2025.
- Funds reported $935K of First Trust Indxx Medical Devices ETF stock for Q3 2025, down 1.7% quarter-over-quarter.
- 0 funds opened new First Trust Indxx Medical Devices ETF positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest First Trust Indxx Medical Devices ETF buyer in Q3 2025 was Jane Street, an estimated $50K added.
- The largest First Trust Indxx Medical Devices ETF seller in Q3 2025 was Arax Advisory Partners, an estimated $42.8K sold.
Based on aggregated 13F filings for Q3 2025.